Download Files:
Products Details
Product Description
– MAGL-IN-9 (compound 16) is a selective and reversible MAGL inhibitor with IC50 2.7 nM[1].
Web ID
– HY-157040
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C25H22F4N2O2S
References
– [1]Di Stefano M, et al. Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors[J]. European Journal of Medicinal Chemistry, 2023: 115916.
Molecular Weight
– 490.51
SMILES
– O=C(N1CCC(CC2=CC=C(F)C(SC3=NC=CC(C(F)(F)F)=C3)=C2)CC1)C4=CC=CC(O)=C4
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– MAGL
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
